Related Experiment Video
Updated: Oct 5, 2025

Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
Bone Involvement in Patients with Spondyloarthropathies
Willem Lems1, Corinne Miceli-Richard2,3, Judith Haschka4,5
1Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands. wf.lems@amsterdamumc.nl.
Spondyloarthropathies (SpA) involve bone loss and new bone formation, like syndesmophytes. Current treatments reduce inflammation but don't inhibit syndesmophyte growth, necessitating further research into pathogenesis and targeted therapies.
Area of Science:
- Rheumatology
- Bone Biology
- Inflammatory Diseases
Background:
- Spondyloarthropathies (SpA) are inflammatory rheumatic diseases causing bone loss and vertebral fractures.
- SpA also features new bone formation in the spine (syndesmophytes).
- Current treatments like TNF inhibitors (TNFi) and IL-17 inhibitors (IL-17i) reduce inflammation but fail to inhibit syndesmophyte formation.
Purpose of the Study:
- To unravel the pathogenesis of syndesmophyte formation and growth in SpA.
- To evaluate new diagnostic and therapeutic options for SpA bone involvement.
- To provide a comprehensive review for basic scientists and clinicians.
Main Methods:
- Review of existing literature on SpA, bone metabolism, and treatment outcomes.
- Analysis of risk factors for radiographic progression in axial SpA (axSpA).
- Evaluation of diagnostic techniques including MRI, low-dose CT, and 18F-fluoride PET-scans.
Main Results:
- Radiographic progression in axSpA is linked to male sex, smoking, HLA-B27, elevated CRP, syndesmophytes, and MRI inflammation.
- TNFi and IL-17i reduce inflammation and symptoms but do not consistently inhibit syndesmophyte formation.
- Advanced imaging (low-dose CT, MRI, PET) and bone turnover markers show promise for early detection and monitoring.
Conclusions:
- More insight into the pathogenesis of bone formation in axSpA is needed.
- Targeted therapies are required to prevent syndesmophyte formation.
- Early detection using advanced imaging and risk factor assessment is crucial for managing SpA bone complications.
More Related Videos
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Spongy Bone
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
Introduction to Joints
Blood and Nerve Supply to the Bones
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Bone Markings
Articulating Projections
Articulating projections are found where two bones meet to form a joint. These structures are usually found at the ends of bones. The largest articulation is a rounded projection called the head, supported by a narrow neck at the ends of...
The Functions of the Skeletal System

